Trending...
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- Tru by Hilton Columbia South Opens to Guests
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
To become the premier provider of internationally sourced, affordable prescription medications for health plans and individuals, Care2Care International is now offering an equity crowdfunding opportunity through TycoonInvest.
PORTSMOUTH, N.H. - WisconsinEagle -- Care2Care International (C2C) is striving to provide value to healthcare plans and individual patients, and its growth potential is significant. This is why we asked our partner TycoonInvest to help us raise $400,000 to create jobs, expand our marketing reach, further develop our patient platform, and invest in sourcing partnerships.
C2C provides international pharmacy mail-order services, and is striving to help patients in the United States fully and easily exercise their right to import prescription drugs for personal use, individually or through their health plan.
To this end, C2C provides a simple solution for procuring US FDA-approved medications delivering huge savings for hundreds of costly prescription drugs.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
More on Wisconsin Eagle
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, which reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
C2C's interests are completely aligned with their clients' as shown by the moderate, win-win performance fee which is a function of the actual savings generated: the more the client saves, the more C2C gets paid.
Care2Care target market is the employer self-funded health plans, whose drug spending represents now roughly 25% of their total costs and is the fastest-growing item. These plans are therefore in dire need of real cost containment solutions.
C2C markets its services directly to employers directly or partnering with consultants, brokers, or providers sharing the same values: deliver a fair and high-value service to American people in search of real solutions for their health needs, at an affordable and transparent cost.
More on Wisconsin Eagle
Care2Care is proud to announce a strategic partnership with an innovative, transparent, 100% pass-through PBM, expanding C2C's offer and expertise to the full pharmacy benefit management. This new service called Care2Care Choice Rx™ will allow C2C to reach out to employers with a comprehensive pharmacy solution to achieve the lowest net cost reference price. At stake: for the employer, a potential cost reduction of 40%+ of Rx expenditures, meaning 10%+ of total health care plan spending; for Care2Care, another revenue stream from a broader range of clients.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone.
For more information about our Reg CF Offering, visit the investment platform at https://tycooninvest.com/care2care.
C2C provides international pharmacy mail-order services, and is striving to help patients in the United States fully and easily exercise their right to import prescription drugs for personal use, individually or through their health plan.
To this end, C2C provides a simple solution for procuring US FDA-approved medications delivering huge savings for hundreds of costly prescription drugs.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
More on Wisconsin Eagle
- Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
- Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
- Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
- Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
- Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, which reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
C2C's interests are completely aligned with their clients' as shown by the moderate, win-win performance fee which is a function of the actual savings generated: the more the client saves, the more C2C gets paid.
Care2Care target market is the employer self-funded health plans, whose drug spending represents now roughly 25% of their total costs and is the fastest-growing item. These plans are therefore in dire need of real cost containment solutions.
C2C markets its services directly to employers directly or partnering with consultants, brokers, or providers sharing the same values: deliver a fair and high-value service to American people in search of real solutions for their health needs, at an affordable and transparent cost.
More on Wisconsin Eagle
- Moor Downs Golf Course Partners With Keeper Goals on New Protective Barrier Netting System
- CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
- Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
- Generator enclosures shelter critical assets from the elements
- Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
Care2Care is proud to announce a strategic partnership with an innovative, transparent, 100% pass-through PBM, expanding C2C's offer and expertise to the full pharmacy benefit management. This new service called Care2Care Choice Rx™ will allow C2C to reach out to employers with a comprehensive pharmacy solution to achieve the lowest net cost reference price. At stake: for the employer, a potential cost reduction of 40%+ of Rx expenditures, meaning 10%+ of total health care plan spending; for Care2Care, another revenue stream from a broader range of clients.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone.
For more information about our Reg CF Offering, visit the investment platform at https://tycooninvest.com/care2care.
Contact
Pascal Orliac
Co-founder and Chief Marketing Officer
www.care2careinternational.com
pascal@care2caremedicaltravel.com
+1 603 781-4947
Pascal Orliac
Co-founder and Chief Marketing Officer
www.care2careinternational.com
pascal@care2caremedicaltravel.com
+1 603 781-4947
Source: Care2Care International
0 Comments
Latest on Wisconsin Eagle
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- TRIO Heating, Air & Plumbing Now Ranks #1 in San Jose
- Milwaukee Job Corps Center Hosts Alumni Day, Calls Alumni to Action on Open Enrollment Campaign
- When The Call Hits Home - Heartfelt Holiday Episode Focusing on First Responders and Family Wellness
- Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
- Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
- A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
